Compare American Financial Group Inc (AFG) vs Appian Corp (APPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Financial Group Inc vs Appian Corp — how do they compare? American Financial Group Inc trades at $144.65 (market cap $11.93B), while Appian Corp trades at $35.5 (market cap $2.55B). The key difference: American Financial Group Inc is far larger — about 4.7× Appian Corp's market cap, and American Financial Group Inc pays a 2.45% dividend while Appian Corp pays none. Which is the better fit depends on your goals.
| AFG | APPN | |
|---|---|---|
Market Cap | $11.93B | $2.55B |
Sector | Financials | Technology |
52-Week High | $148.71 | $45.64 |
52-Week Low | $124.18 | $18.72 |
Enterprise Value | $12.31B | $2.68B |
Dividend Yield | 2.45% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
American Financial Group (AFG) trades at $145.59, down 0.78% on the day, with strong technical momentum indicated by bullish moving averages. The company reported solid Q2 2026 earnings of $2.82 per share, beating estimates by 21.6%, driven by record property and casualty operating income. Recent news highlights strong underwriting margins and premium growth, while institutional activity shows mixed positioning with some funds increasing stakes and others reducing holdings.
AFG presents a compelling investment case with a reasonable P/E of 12.73 and strong ROE of 20.41%, supported by consistent dividend payments. The consensus price target of $159.00 suggests 9.2% upside potential. Key risks include competitive pressures in insurance markets and potential margin compression. Analyst sentiment is cautiously optimistic with 41% buy ratings, though the majority maintain hold recommendations awaiting clearer growth catalysts.
Appian (APPN) surged 13.91% to $34.64 following strong Q2 2026 earnings that exceeded expectations, with cloud subscription revenue growing 23% year-over-year. The stock trades near its pivot point of $34 with bullish technical signals from moving averages, though RSI levels suggest potential overbought conditions. Revenue growth has accelerated from $617M in 2024 to $727M in 2025, with the company achieving its first profitable year with $1.23M net income after several years of losses.
Appian demonstrates improving fundamentals with consistent revenue growth and recent profitability, though negative equity and high debt levels present risks. Analyst sentiment is mixed with 31.58% buy ratings but a consensus price target of $32.50 below current levels. The AI-driven workflow platform shows strong enterprise adoption, but investors should weigh growth potential against valuation concerns and competitive pressures in the low-code automation space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Financial Group Inc
American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. American also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. American's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.
Read more on AFG →About Appian Corp
Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.
Read more on APPN →
